Glipita-M 50/1000 is a combination tablet containing:
-
Sitagliptin Phosphate Monohydrate (equivalent to Sitagliptin 50 mg)
-
Metformin Hydrochloride 1000 mg
Manufactured by Beximco Pharmaceuticals Ltd. and marketed by Standard Generics Limited in Nigeria, Glipita-M is registered with NAFDAC under NRN B4-7628 .
Uses
Glipita-M is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate .
